Continued Expansion of Sales and Profit
First written in FY2016. 7 of 40 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-08-14.
Linical moved to the "Worse" side of this theme in 2026, 7 years after the typical company in this theme (2019).
15 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「For the fiscal year, consolidated net sales decreased 17.0% year on year to ¥8,665 million. Although Taiwan and China secured operating profit, South Korea narrowed its operating loss by controlling costs despite lower sales, and Japan narrowed its operating loss on higher sales, the United States and Europe recorded substantial sales declines because delays in starting several large new projects and other factors prevented them from offsetting the decline in sales following the completion of large projects. As a result, the operating loss was ¥2,073 million, compared with an operating loss of ¥583 million in the previous period, and the ordinary loss was ¥2,023 million, compared with an ordinary loss of ¥498 million. In addition, the Company recognized impairment losses on goodwill related to the European business and fixed assets related to the Japanese business at the end of the fiscal year, and reduced deferred tax assets. Consequently, net loss attributable to owners of the parent was ¥3,329 million, compared with a net loss of ¥539 million in the previous period.」
For the full year, sales declined 17.0%, while the operating loss widened from ¥583 million to ¥2,073 million, the ordinary loss from ¥498 million to ¥2,023 million, and net loss attributable to owners of the parent from ¥539 million to ¥3,329 million. For the next fiscal year, the Company forecasts net sales of ¥10,680 million, operating profit of ¥256 million, ordinary profit of ¥250 million and net profit attributable to owners of the parent of ¥180 million, while stating that performance is expected to remain challenging initially and that it will pursue workforce reductions, higher utilization and tighter expense management. - FY2026-H1Interim sales decline and worsening losses at every profit levelAnnual report
「During the first six months of the fiscal year, consolidated net sales decreased 10.4% year on year to ¥4,859 million due to lower sales in the United States and South Korea. In terms of profit, Taiwan and China moved into operating profit, while Japan narrowed its operating loss on higher sales and South Korea narrowed its operating loss by controlling costs despite lower sales. However, the United States moved into operating loss because the decline in sales following the completion of a large project could not be offset by winning new projects, and Europe's operating loss also widened. As a result, the operating loss was ¥511 million, compared with an operating loss of ¥192 million in the previous period. The ordinary loss was ¥543 million, compared with an ordinary loss of ¥239 million in the previous period, due to foreign exchange losses and other factors. In addition, after carefully reviewing the recoverability of deferred tax assets in light of the current business environment and future performance trends, the Company reduced deferred tax assets by ¥408 million during the first six months and recorded the amount as an adjustment to income taxes. Consequently, interim net loss attributable to owners of the parent was ¥927 million, compared with an interim net loss attributable to owners of the parent of ¥280 million in the previous period.」
Sales declined 10.4% year on year, while the operating loss widened from ¥192 million to ¥511 million, the ordinary loss from ¥239 million to ¥543 million, and the interim net loss attributable to owners of the parent from ¥280 million to ¥927 million. - FY2025-H1Interim sales decline and losses at every profit levelAnnual report
「During the first six months of the fiscal year, consolidated net sales decreased 10.5% year on year to ¥5,426 million, as sales in Japan and Asia declined substantially despite a substantial increase in sales in the United States. In terms of profit, the United States, where sales were strong, recorded a substantial increase in operating profit, and Europe narrowed its loss year on year. However, Japan and Asia recorded operating losses due to substantial sales declines, resulting in an operating loss of ¥192 million, compared with operating profit of ¥421 million in the previous period. An ordinary loss of ¥239 million was recorded, compared with ordinary profit of ¥483 million in the previous period, due to foreign exchange losses. Although no extraordinary loss was recorded in the current period, interim net loss attributable to owners of the parent was ¥280 million, compared with interim net profit attributable to owners of the parent of ¥178 million in the previous period, due to the factors described above.」
Although sales and profit increased in the United States and Europe's loss narrowed, consolidated sales declined 10.5%, and the Company moved into an operating loss, ordinary loss and interim net loss attributable to owners of the parent. - FY2024Full-year sales and profit decline, with higher sales and profit planned for the next periodAnnual report
「For the fiscal year, net sales decreased 1.7% year on year to ¥12,307 million. Although profit increased in the United States and South Korea, Europe and other regions recorded operating losses, and Japan also reported lower profit, resulting in operating profit of ¥725 million, down 42.3% year on year. For the next fiscal year, the Company forecasts consolidated net sales of ¥12,669 million, up 2.9% year on year, operating profit of ¥1,009 million, up 39.0%, ordinary profit of ¥1,047 million, up 32.5%, and profit attributable to owners of the parent of ¥697 million, up 106.1%.」
Although net sales, operating profit, ordinary profit and profit attributable to owners of the parent all declined in the current period, the Company disclosed a plan for higher sales and profit for the fiscal year ending March 2025. - FY2024-Q3Flat sales, lower operating profit, lower ordinary profit, lower net profitAnnual report
「During the first nine months of the fiscal year, net sales increased to ¥9,248 million, up 0.0% year on year, as the United States and South Korea performed strongly and increased sales, and the yen remained weak against major currencies, despite lower sales in Japan, Europe and other regions. Operating profit decreased 13.4% year on year to ¥641 million. Although operating profit increased in the United States and South Korea, Europe and other regions recorded operating losses, and Japan also reported lower profit. Ordinary profit decreased 17.7% year on year to ¥632 million. Profit attributable to owners of the parent decreased 56.1% year on year to ¥253 million, as the current period incurred ¥148 million in business structure improvement expenses related to the integration of the management control systems of the European and U.S. subsidiaries, whereas insurance proceeds were received in the previous period.」
Net sales were flat, up 0.0% year on year, while operating profit declined 13.4%, ordinary profit declined 17.7% and profit attributable to owners of the parent declined 56.1%. Compared with the previous period's higher sales, lower operating profit, lower ordinary profit and higher net profit, net profit also moved into decline. - FY2024-Q2Higher sales, higher operating profit, lower ordinary profit and lower net incomeAnnual report
「During the first six months of the fiscal year, consolidated net sales increased to ¥6,064 million, up 2.4% year on year, despite lower sales in Europe and other regions, as the United States performed strongly and generated a substantial increase in sales, while the yen weakened against major currencies. Operating profit increased 12.8% year on year to ¥421 million, although Europe remained in operating loss in the second quarter following the first quarter, as operating profit increased in the United States and Japan. Ordinary profit decreased 21.3% year on year to ¥483 million, as foreign exchange gains of ¥69 million on foreign-currency deposits and other items, together with other gains, were lower than in the previous period. Profit attributable to owners of the parent decreased 61.8% year on year to ¥178 million, as the current period incurred ¥147 million in business structure improvement expenses related to the integration of the management control systems of the European and U.S. subsidiaries, whereas insurance proceeds were received in the previous period.」
Consolidated net sales increased 2.4% year on year and operating profit rose 12.8%, while ordinary profit declined 21.3% and profit attributable to owners of the parent declined 61.8%, resulting in divergent trends at each profit level. - FY2024-Q1Revenue growth, return to operating profitability, ordinary profit growth and net income declineAnnual report
「For the cumulative first quarter of the fiscal year, consolidated revenue increased 7.4% year on year to ¥3,082 million, as substantial revenue growth in the United States and South Korea, together with the weaker yen, more than offset revenue declines in Japan and Europe. Operating profit was ¥112 million, compared with an operating loss of ¥26 million in the year-earlier period, as the United States and South Korea got off to strong starts and Japan secured profit at a level comparable to the previous fiscal year. Ordinary profit increased 87.5% to ¥168 million due in part to foreign exchange gains of ¥58 million on foreign currency deposits and other assets. Quarterly net income attributable to owners of the parent decreased 95.4% to ¥3 million, as the previous fiscal year included insurance proceeds while the current fiscal year included ¥104 million in business restructuring costs associated with integrating the management systems of the European and US subsidiaries.」
Consolidated revenue increased 7.4%, operating profit turned from a loss in the year-earlier period to a profit of ¥112 million, and ordinary profit increased 87.5%. However, due to the absence of the insurance proceeds received in the previous fiscal year and the recording of business restructuring costs, quarterly net income attributable to owners of the parent decreased 95.4%. - FY2023-Q3Revenue growth, operating profit decline, ordinary profit decline and net income growthAnnual report
「Revenue increased 7.3% year on year to ¥9,246 million, as the European and US businesses generated higher revenue and the weaker yen boosted the earnings of overseas subsidiaries. Although an operating loss was recorded in the first quarter because the start of major international joint trials in the United States and Europe was delayed due in part to the Russia-Ukraine war, both the European and US businesses improved from the second quarter onward, bringing cumulative third-quarter operating profit to ¥740 million, down 11.5% year on year. Ordinary profit decreased 9.2% to ¥768 million, despite foreign exchange gains of ¥57 million on foreign currency deposits and other assets. Quarterly net income attributable to owners of the parent increased 10.0% to ¥577 million due in part to insurance proceeds related to the cyberattack that occurred in the previous year and gains on the liquidation of a subsidiary.」
For the cumulative third quarter, revenue increased 7.3%, while operating profit decreased 11.5% and ordinary profit decreased 9.2%. Quarterly net income attributable to owners of the parent increased 10.0%, resulting in revenue growth, operating profit decline, ordinary profit decline and net income growth. - FY2023-Q2Revenue growth, operating profit decline, ordinary profit growth and net income growthAnnual report
「Revenue increased 7.2% year on year to ¥5,920 million, as the European business generated higher revenue and the weaker yen boosted the earnings of overseas subsidiaries. Although an operating loss was recorded in the first quarter because the start of major international joint trials in the United States and Europe was delayed due in part to the Russia-Ukraine war, both the European and US businesses improved in the second quarter, bringing cumulative operating profit to ¥373 million, down 26.4% year on year. Ordinary profit increased 23.9% to ¥614 million due in part to foreign exchange gains of ¥265 million on foreign currency deposits and other assets. Quarterly net income attributable to owners of the parent increased 85.6% to ¥468 million due in part to insurance proceeds related to the cyberattack that occurred in the previous year and gains on the liquidation of a subsidiary.」
Revenue increased 7.2% year on year, while operating profit decreased 26.4% due to delays in the start of major international joint trials. Ordinary profit increased 23.9% due to foreign exchange gains, and quarterly net income attributable to owners of the parent increased 85.6%, resulting in divergent trends across profit levels. - FY2023-Q1Revenue growth, operating loss, ordinary profit decline and net income growthAnnual report
「For the cumulative first quarter of the fiscal year, revenue increased 3.0% year on year to ¥2,868 million, due to revenue growth in Japan and the weaker yen. Profitability got off to a strong start as Japan’s revenue increased and lean operations continued from the previous fiscal year. However, operating loss was recorded because staffing levels were increased in the United States, Europe and South Korea to support the launch of 10 or more new projects and additional work hours scheduled from the second quarter onward, while the start of major international joint trials in the United States and Europe was delayed following revisions to trial plans by the sponsors, temporarily reducing personnel utilization. Group-wide operating loss was ¥26 million, compared with operating profit of ¥145 million in the year-earlier period. The aforementioned trials began in July, and utilization is expected to improve going forward with the launch of multiple new projects and additional work hours scheduled from the second quarter onward. Ordinary profit decreased 36.0% year on year to ¥89 million, due in part to foreign exchange gains of ¥124 million on foreign currency deposits and other assets. Net income attributable to owners of the parent increased 13.8% to ¥76 million due to the receipt of insurance proceeds.」
Revenue increased 3.0%, while operating profit turned from profit of ¥145 million in the year-earlier period to an operating loss of ¥26 million due to delays in the start of major international joint trials in the United States and Europe. Ordinary profit decreased 36.0%, but quarterly net income attributable to owners of the parent increased 13.8% due to the receipt of insurance proceeds. - FY2022-Q3AdvancedAnnual report
「For the cumulative third quarter of the fiscal year, revenue reached a record high for a cumulative third quarter of ¥8,613 million, up 14.4% year on year. Operating profit and ordinary profit recovered to levels recorded in the third quarter of the fiscal year ended March 2020, immediately before the COVID-19 outbreak. Operating profit increased 302.9% to ¥836 million, while ordinary profit increased 683.8% to ¥846 million due in part to foreign exchange gains of ¥24 million on foreign currency deposits and other assets.」
Revenue reached a record high for a cumulative third quarter, while operating profit and ordinary profit recovered to the profit levels recorded in the third quarter of the fiscal year ended March 2020, before the COVID-19 outbreak. - FY2022-Q2AdvancedAnnual report
「As a result, for the cumulative second quarter of the fiscal year, revenue increased 10.9% year on year to ¥5,522 million, as substantial improvement in Europe and the United States offset performance in Japan and Asia, which were heavily affected by COVID-19. Operating profit increased 173.0% to ¥507 million. Ordinary profit increased 259.3% to ¥496 million, due in part to lower foreign exchange losses. Quarterly net income attributable to owners of the parent was ¥252 million, compared with a net loss attributable to owners of the parent of ¥13 million in the year-earlier period, resulting in a substantial return to profitability despite settlement payments and related legal fees arising from the resolution of a dispute concerning projects undertaken by Accelovance, Inc., the predecessor of Linical Accelovance America, Inc., before its acquisition.」
Improved performance in Europe and the United States lifted revenue, operating profit and ordinary profit above the year-earlier period, while quarterly net income attributable to owners of the parent turned from a loss in the year-earlier period to a profit of ¥252 million. - FY2022-Q1AdvancedAnnual report
「As a result, for the cumulative first quarter of the fiscal year, revenue increased 14.9% year on year to ¥2,784 million, as improved performance in Europe and the United States offset performance in Japan and Asia, which were heavily affected by COVID-19. Operating profit was ¥145 million, a substantial turnaround from the operating loss of ¥150 million in the year-earlier period.」
Improved performance in Europe and the United States drove revenue growth of 14.9% year on year, and operating profit turned from a loss of ¥150 million in the year-earlier period to a profit of ¥145 million. Ordinary profit of ¥140 million and quarterly net income attributable to owners of the parent of ¥67 million were also positive, indicating a recovery from the year-earlier period. - FY2021Full-year revenue decline and substantial operating profit decline, but higher net income; guidance disclosed for the next fiscal yearAnnual report
「For the fiscal year, revenue decreased 6.0% year on year to ¥10,279 million. Operating profit decreased 54.9% to ¥453 million due to lower utilization resulting from the decline in revenue and other factors. Ordinary profit decreased 35.9% to ¥588 million due to government subsidies received by an overseas subsidiary. Net income attributable to owners of the parent increased 11.8% to ¥539 million. For the next fiscal year, ending March 2022, revenue is forecast at ¥10,700 million, up 4.1% year on year, and operating profit at ¥683 million, up 50.6%.」
For the full year, revenue, operating profit and ordinary profit declined, while net income attributable to owners of the parent increased. For the next fiscal year, the company presented targets of revenue of ¥10,700 million and operating profit of ¥683 million. - FY2021-Q3Lower sales and continued sharp decline in profitsAnnual report
「As a result, for the cumulative third quarter of the fiscal year, revenue decreased 8.2% year on year to ¥7,532 million. Operating profit decreased 76.1% to ¥207 million due to lower utilization resulting from the decline in revenue and other factors. Ordinary profit decreased 86.1% to ¥107 million due to foreign exchange losses of ¥129 million and other losses on foreign currency deposits and other assets caused by the stronger yen. Quarterly net income attributable to owners of the parent decreased 60.6% to ¥157 million, as legal fees and other costs related to arbitration concerning projects undertaken by Accelovance, Inc., the predecessor of Linical Accelovance America, Inc. (LAA), before its acquisition, negotiations with the seller of LAA, and settlement payments to customers were incurred, while tax refunds and other items arose in the United States.」
For the cumulative third quarter, revenue, operating profit, ordinary profit and quarterly net income attributable to owners of the parent all fell below the year-earlier period. Although the declines in operating profit and ordinary profit widened, quarterly net income attributable to owners of the parent remained positive. - FY2021-Q2Revenue decline, substantial profit decline and quarterly net loss attributable to owners of the parentAnnual report
「As a result, for the cumulative second quarter of the fiscal year, revenue decreased 7.6% year on year to ¥4,981 million. Operating profit decreased 67.4% to ¥185 million due to lower utilization resulting from the decline in revenue and other factors. Ordinary profit decreased 71.5% to ¥138 million due to foreign exchange losses on foreign currency deposits and other assets caused by the stronger yen. Quarterly net loss attributable to owners of the parent was ¥13 million, compared with net income attributable to owners of the parent of ¥230 million in the year-earlier period, due to legal fees and other costs related to arbitration concerning projects undertaken by Accelovance, Inc., the predecessor of Linical Accelovance America, Inc. (LAA), before its acquisition, negotiations with the seller of LAA, and tax expenses.」
For the cumulative second quarter, revenue decreased 7.6%, operating profit decreased 67.4% and ordinary profit decreased 71.5%, while quarterly net income attributable to owners of the parent turned into a net loss of ¥13 million. - FY2021-Q1Lower revenue, operating loss, ordinary loss and net lossAnnual report
「As a result, for the cumulative first quarter of the fiscal year, revenue decreased 9.6% year on year to ¥2,424 million. Operating loss was ¥150 million, compared with operating profit of ¥129 million in the year-earlier period, due to lower utilization resulting from the decline in revenue and other factors, marking the first operating loss since listing. Ordinary loss was ¥158 million, compared with ordinary profit of ¥48 million in the year-earlier period, due to foreign exchange losses on foreign currency deposits and other assets caused by the stronger yen. Quarterly net loss attributable to owners of the parent was ¥199 million, compared with net income attributable to owners of the parent of ¥15 million in the year-earlier period, due to legal fees and other costs related to arbitration concerning projects undertaken by Accelovance, Inc., the predecessor of Linical Accelovance America, Inc. (LAA), before its acquisition, and negotiations with the seller of LAA.」
Revenue decreased 9.6% year on year, and operating profit turned into the first operating loss since listing. Ordinary profit and quarterly net income attributable to owners of the parent also turned into losses, worsening from revenue and profit declines to revenue decline and losses at each profit level. - FY2020Revenue decline, operating profit decline, ordinary profit decline and net income declineAnnual report
「For the fiscal year, revenue decreased 3.3% year on year to ¥10,935 million. Operating profit decreased 17.1% to ¥1,005 million. Ordinary profit decreased 26.7% to ¥918 million, as the previous fiscal year included foreign exchange gains of ¥67 million on foreign currency deposits and other assets due to the weaker yen, whereas the current fiscal year included foreign exchange losses of ¥48 million and other losses due to the stronger yen. Net income attributable to owners of the parent decreased 15.0% to ¥482 million due to legal fees and other costs incurred in connection with arbitration proceedings in the United States, as announced in the 18 October 2019 notice titled “Notice Concerning Filing of Arbitration Against Our Overseas Subsidiary,” and costs related to the internal reorganization integrating LAA’s European subsidiaries into LINICAL Europe Holding GmbH to strengthen the effectiveness of group management and accelerate decision-making.」
For the full year, revenue, operating profit, ordinary profit and net income attributable to owners of the parent all fell below the year-earlier period. - FY2020-Q3Continued revenue decline, operating profit decline, ordinary profit decline and net income declineAnnual report
「For the cumulative third quarter of the fiscal year, revenue decreased 4.3% year on year to ¥8,205 million. Operating profit decreased 12.4% to ¥870 million due to the decline in revenue for the reasons described above and legal fees incurred for negotiations with the seller over closing price adjustments related to the acquisition of a US subsidiary. Ordinary profit decreased 23.8% to ¥776 million, as the year-earlier period included foreign exchange gains of ¥45 million on foreign currency deposits and other assets due to the weaker yen, whereas the current period included foreign exchange losses of ¥62 million and other losses due to the stronger yen. Quarterly net income attributable to owners of the parent decreased 12.1% to ¥398 million due to legal fees and other costs incurred in connection with arbitration proceedings in the United States, as announced in the 18 October 2019 notice titled “Notice Concerning Filing of Arbitration Against Our Overseas Subsidiary,” and costs related to the internal reorganization integrating LAA’s European subsidiaries into LINICAL Europe Holding GmbH to strengthen the effectiveness of group management and accelerate decision-making.」
For the cumulative third quarter, revenue, operating profit, ordinary profit and quarterly net income attributable to owners of the parent all fell below the year-earlier period, and revenue and profit declines continued. - FY2020-Q2Revenue down, operating profit down, ordinary profit downAnnual report
「Revenue decreased 4.0% year on year to ¥5,389 million, partly because the revenue of overseas subsidiaries declined when translated into yen as the yen appreciated, and because several major projects in Japan were completed from the previous fiscal year into the current fiscal year, creating a gap before new projects began. Through the expansion of our group’s global contracted-services structure and sales activities in Japan, Asia, the United States and Europe, we won multiple new projects, including global clinical trials, despite competition from major foreign-affiliated global CROs, and the order backlog continued to increase steadily. Operating profit decreased 11.7% to ¥571 million, broadly in line with the initial forecast, due in part to legal fees incurred for negotiations with the seller over closing price adjustments related to the acquisition of a US subsidiary. Ordinary profit decreased 35.2% to ¥484 million, as the year-earlier period included foreign exchange gains of ¥116 million on foreign currency deposits and other assets due to the weaker yen, whereas the current period included foreign exchange losses of ¥63 million and other losses due to the stronger yen. Quarterly net income attributable to owners of the parent decreased 40.3% to ¥230 million due to legal fees and other costs incurred in connection with arbitration proceedings in the United States, as announced in the 18 October 2019 notice titled “Notice Concerning Filing of Arbitration Against Our Overseas Subsidiary.”」
Revenue decreased 4.0% year on year, operating profit decreased 11.7%, ordinary profit decreased 35.2% and quarterly net income attributable to owners of the parent decreased 40.3%, changing from revenue decline and operating profit growth in the previous quarter to declines in both revenue and operating profit. - FY2020-Q1Lower sales, higher operating income and lower ordinary incomeAnnual report
「However, revenue decreased 2.9% year on year to ¥2,680 million, partly because the recognition of revenue from milestone contracts in Japan was delayed and the strong performance of overseas subsidiaries declined when translated into yen as the yen appreciated. Through the expansion of our group’s global contracted-services structure and sales activities in Japan, Asia, the United States and Europe, we won multiple new projects, including global clinical trials, despite competition from major foreign-affiliated global CROs, and the order backlog was steadily increasing as of the end of the first quarter. Operating profit increased 56.9% to ¥129 million despite higher personnel expenses from upfront personnel investment, promotions and salary increases, and higher rent, because the temporary burden of acquisition-related costs associated with the acquisition of LAA in the previous fiscal year ended and the effects of LAA’s cost-cutting measures began to emerge. Ordinary profit decreased 67.5% to ¥48 million due to foreign exchange losses of ¥71 million on foreign currency deposits and other assets caused by the stronger yen. Quarterly net income attributable to owners of the parent decreased 60.7% to ¥15 million.」
In the first quarter, revenue decreased 2.9% year on year, while operating profit increased 56.9%. However, ordinary profit decreased 67.5% and quarterly net income attributable to owners of the parent decreased 60.7% due to foreign exchange losses caused by the stronger yen, resulting in divergent trends in revenue and profit. - FY2019Continued revenue growth and profit decline (wider profit decline)Annual report
「For the fiscal year, revenue increased 24.1% year on year to ¥11,313 million due to an increase in contracted projects and the inclusion of revenue from LAA and its subsidiaries following the acquisition of LAA. Operating profit decreased 34.3% to ¥1,212 million. Although revenue increased year on year, it was below the initial forecast, and the company was unable to absorb higher personnel expenses from upfront personnel investment, the inclusion of cost of sales and selling, general and administrative expenses from LAA and its subsidiaries following the acquisition, and higher acquisition-related costs and goodwill amortization associated with the acquisition. Ordinary profit decreased 31.4% to ¥1,253 million, as interest expenses increased while foreign exchange gains arose on foreign currency deposits and other assets due to the weaker yen. Net income attributable to owners of the parent decreased 56.1% to ¥568 million due to the recording of temporary business restructuring costs related to the reorganization of LAA’s US locations and surplus personnel, and the inability at this point to recognize as deferred tax assets the future tax benefits of tax loss carryforwards and other items arising at LAA.」
Revenue increased 24.1%, including through the inclusion of revenue from the acquisition of LAA, while operating profit decreased 34.3%, ordinary profit decreased 31.4% and net income attributable to owners of the parent decreased 56.1%. Revenue growth and profit decline from the acquisition contribution continued for the full year, with the decline in profit widening. - FY2019-Q3Continued revenue growth and profit decline from acquisition contribution (wider profit decline)Annual report
「For the cumulative third quarter of the fiscal year, revenue increased 27.7% year on year to ¥8,574 million due to an increase in contracted projects and the inclusion of revenue from LAA and its subsidiaries following the acquisition of LAA. Operating profit decreased 25.7% to ¥1,001 million. Although revenue increased year on year, it was below the initial forecast, and the company was unable to absorb higher personnel expenses from upfront personnel investment, the inclusion of cost of sales and selling, general and administrative expenses from LAA and its subsidiaries following the acquisition, and higher acquisition-related costs and goodwill amortization associated with the acquisition. Ordinary profit decreased 23.2% to ¥1,027 million, as interest expenses arose while foreign exchange gains on foreign currency deposits and other assets arose due to the weaker yen. Quarterly net income attributable to owners of the parent decreased 49.1% to ¥458 million due to the recording of temporary business restructuring costs related to the reorganization of LAA’s US locations and surplus personnel, and the inability at this point to recognize as deferred tax assets the future tax benefits of tax loss carryforwards arising at LAA.」
Revenue increased 27.7% due to the inclusion of revenue from the acquisition of LAA, while operating profit decreased 25.7%, ordinary profit decreased 23.2% and quarterly net income attributable to owners of the parent decreased 49.1%, with revenue growth and profit decline from the acquisition contribution continuing and the decline in profit widening. - FY2019-Q2Continued revenue growth and profit decline from acquisition contributionAnnual report
「As a result, for the cumulative second quarter of the fiscal year, revenue increased 29.9% year on year to ¥5,612 million due to an increase in contracted projects and the inclusion of revenue from LAA and its subsidiaries following the acquisition of LAA. Operating profit decreased 22.3% to ¥651 million. Although revenue increased year on year, it was below the initial forecast, and the company was unable to absorb higher personnel expenses from upfront personnel investment, the inclusion of cost of sales and selling, general and administrative expenses from LAA and its subsidiaries following the acquisition, and higher acquisition-related costs and goodwill amortization associated with the acquisition.」
Revenue increased due to the inclusion of revenue from the acquisition of LAA, while operating profit decreased 22.3% year on year, ordinary profit decreased 10.1% and quarterly net income attributable to owners of the parent decreased 27.5%, with revenue growth and profit decline continuing after the acquisition. - FY2019-Q1Wider profit decline despite revenue growth from acquisition contributionAnnual report
「Against the business backdrop described above, for the cumulative first quarter of the fiscal year, revenue increased 29.1% year on year to ¥2,759 million due to an increase in contracted projects and the inclusion of revenue from Accelovance, Inc. (now Linical Accelovance America, Inc.) and its subsidiaries following the acquisition. Operating profit decreased 65.8% to ¥86 million due to higher personnel expenses from upfront personnel investment, as well as higher acquisition-related costs and amortization of goodwill associated with the acquisition of Accelovance, Inc. (now Linical Accelovance America, Inc.). Ordinary profit decreased 41.3% to ¥151 million, as foreign exchange gains of ¥72 million arose on foreign currency deposits and other assets due to the weaker yen. Quarterly net income attributable to owners of the parent was ¥42 million, down 73.4%.」
Revenue increased 29.1% due to the inclusion of revenue from the acquisition of Accelovance, while operating profit decreased 65.8%, ordinary profit decreased 41.3% and quarterly net income attributable to owners of the parent decreased 73.4%. Both the increase in revenue and the decline in profit widened from the revenue growth and profit decline recorded in the first quarter of the previous fiscal year. - FY2018Revenue Up, Profit DownAnnual report
「Against this backdrop, for the fiscal year, revenue increased 9.1% year on year to ¥9,113 million, while operating profit decreased 13.2% to ¥1,846 million, ordinary profit decreased 12.0% to ¥1,826 million, and net income attributable to owners of the parent decreased 10.5% to ¥1,295 million, resulting in revenue growth and profit decline.」
For the full year, revenue increased 9.1%, while operating profit, ordinary profit and net income attributable to owners of the parent all declined, resulting in revenue growth and profit decline. - FY2018-Q3Revenue growth and profit decline (narrower profit decline)Annual report
「For the cumulative third quarter of the fiscal year, revenue increased 8.3% year on year to ¥6,712 million due to an increase in contracted projects. Operating profit decreased 18.3% to ¥1,348 million due to higher personnel expenses from upfront personnel investment and costs associated with relocating the Tokyo office. Ordinary profit decreased 17.1% to ¥1,338 million due in part to valuation losses on investment securities. Quarterly net income attributable to owners of the parent was ¥900 million, down 15.5%.」
Revenue increased 8.3%, while operating profit, ordinary profit and quarterly net income attributable to owners of the parent all declined. Compared with the cumulative second quarter, the decline in operating profit narrowed from 25.1% to 18.3%. - FY2018-Q2Revenue growth and profit decline (wider profit decline)Annual report
「Against the business backdrop described above, for the cumulative second quarter of the fiscal year, revenue increased 7.2% year on year to ¥4,319 million due to an increase in contracted projects. Operating profit decreased 25.1% to ¥839 million due to higher personnel expenses from upfront personnel investment and costs associated with relocating the Tokyo office. Ordinary profit decreased 21.8% to ¥838 million, as foreign exchange gains arose on foreign currency deposits and other assets due to the weaker yen, while valuation losses on investment securities were also recorded. Quarterly net income attributable to owners of the parent was ¥537 million, down 28.2%.」
Revenue increased 7.2% due to an increase in contracted projects, while operating profit decreased 25.1%, ordinary profit decreased 21.8% and quarterly net income attributable to owners of the parent decreased 28.2%. The decline in profit widened from the revenue growth and slight profit decline recorded in the year-earlier period. - FY2018-Q1Revenue Up, Profit DownAnnual report
「Against the business backdrop described above, for the cumulative first quarter of the fiscal year, revenue increased 9.5% year on year to ¥2,136 million due to an increase in contracted projects. Operating profit decreased 29.8% to ¥253 million due to higher personnel expenses from upfront personnel investment and costs associated with relocating the Tokyo office. Ordinary profit decreased 19.2% to ¥258 million, as foreign exchange gains of ¥8 million arose on foreign currency deposits and other assets due to the weaker yen. Quarterly net income attributable to owners of the parent was ¥160 million, down 29.4%.」
Revenue increased 9.5% year on year due to an increase in contracted projects, while operating profit, ordinary profit and quarterly net income attributable to owners of the parent all declined, resulting in revenue growth and profit decline. - FY2017AdvancedAnnual report
「Against this backdrop, for the fiscal year, revenue increased 9.0% year on year to ¥8,355 million, operating profit increased 5.8% to ¥2,128 million, ordinary profit increased 4.6% to ¥2,076 million, and net income attributable to owners of the parent increased 8.8% to ¥1,447 million, resulting in both revenue and profit growth.」
For the full year, revenue, operating profit, ordinary profit and net income attributable to owners of the parent all exceeded the year-earlier period, demonstrating continued revenue and profit growth in the figures. - FY2017-Q3AdvancedAnnual report
「For the cumulative third quarter of the fiscal year, revenue increased 8.1% year on year to ¥6,197 million, operating profit increased 4.8% to ¥1,650 million, ordinary profit increased 2.9% to ¥1,614 million, and quarterly net income attributable to owners of the parent increased 4.3% to ¥1,066 million. The group achieved both revenue and profit growth, as steady growth at overseas subsidiaries offset higher cost of sales, selling, general and administrative expenses from upfront personnel investment and foreign exchange losses caused by the stronger yen.」
Revenue, operating profit, ordinary profit and quarterly net income attributable to owners of the parent all exceeded the year-earlier period, turning from revenue growth and profit decline in the previous quarter to growth in both revenue and profit. - FY2017-Q2Revenue Up, Profit DownAnnual report
「Against this backdrop, for the cumulative second quarter of the fiscal year, revenue increased 6.6% year on year to ¥4,029 million, as strong domestic performance and steady growth at overseas subsidiaries offset the impact of the rapid appreciation of the yen. Operating profit, however, decreased 1.0% to ¥1,120 million, due to higher cost of sales, selling, general and administrative expenses, particularly from upfront personnel investment in Japan, and the reduction in the yen-denominated contribution from overseas subsidiaries caused by the stronger yen. Ordinary profit decreased 5.8% to ¥1,071 million, due in part to foreign exchange losses on foreign currency-denominated assets held as a result of the stronger yen. Quarterly net income attributable to owners of the parent was ¥747 million, up 0.1%.」
For the cumulative second quarter, revenue increased 6.6%, while operating profit decreased 1.0%, ordinary profit decreased 5.8% and quarterly net income attributable to owners of the parent increased 0.1%, resulting in divergent trends in revenue and profit. - FY2017-Q1AdvancedAnnual report
「For the cumulative first quarter of the fiscal year, revenue was ¥1,950 million, up 13.0% year on year, and operating profit was ¥361 million, up 24.9%. Ordinary profit was ¥320 million, up 0.6%, as foreign exchange losses of ¥36 million arose on foreign currency deposits and other assets due to the rapid appreciation of the yen. Net income attributable to owners of the parent was ¥226 million, up 20.2%.」
Revenue, operating profit and quarterly net income attributable to owners of the parent exceeded the year-earlier period, showing measurable progress in continued revenue and profit growth. - FY2016First statedAnnual report
「Our group will pursue growth by focusing on the following key initiatives, with the aim of achieving continued growth in revenue and profit and strengthening the internal control framework that supports it.」
Continued growth in revenue and profit is positioned as a management priority alongside strengthening the internal control framework.